Futura Medical (LON:FUM) Shares Down 11.7% – Should You Sell?

Futura Medical plc (LON:FUM) shares fell 11.7% during mid-day trading on Wednesday . The company traded as low as GBX 0.53 and last traded at GBX 0.53. Approximately 3,180,240 shares changed hands during trading, a decline of 48% from the average daily volume of 6,068,521 shares. The stock had previously closed at GBX 0.60.

Futura Medical Price Performance

The company has a market cap of £3.23 million, a PE ratio of -0.20 and a beta of 0.01. The company has a fifty day moving average price of GBX 0.85 and a 200 day moving average price of GBX 1.08.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The company had revenue of GBX 170 million during the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. As a group, sell-side analysts predict that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.